Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma

Autoimmune hemolytic anemia secondary to nivolumab occurred in a patient with melanoma.

Saved in:
Bibliographic Details
Published inJournal of cutaneous immunology and allergy Vol. 4; no. 5; pp. 141 - 142
Main Authors Nakajima, Koji, Korekawa, Ayumi, Rokunohe, Daiki, Nakano, Hajime, Sawamura, Daisuke
Format Journal Article
LanguageEnglish
Published Tokyo Frontiers Media SA 01.10.2021
Frontiers Media S.A
Subjects
Anemia
Immunotherapy
jaundice
Laboratories
Melanoma
Metastasis
Monoclonal antibodies
nivolumab
Skin cancer
Targeted cancer therapy
Online AccessGet full text

Cover

More Information
Summary:Autoimmune hemolytic anemia secondary to nivolumab occurred in a patient with melanoma.
ISSN:2574-4593
2574-4593
DOI:10.1002/cia2.12173